Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynecol Pathol Retrieve available abstracts of 101 articles: HTML format

Single Articles

September 2020
1. HEAYN M, Skvarca LB, Zhu L, Edwards RP, et al
   Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant Chemotherapy.
   Int J Gynecol Pathol. 2020 Sep 4. doi: 10.1097/PGP.0000000000000706.
   PubMed     Abstract available
   
   
   March 2020
2. BROUWER J, Strickland KC, Ning G, Schmelkin CB, et al
   Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
   Int J Gynecol Pathol. 2020;39:163-169.
   PubMed     Abstract available
   
   
   
3. ZHANG X, Guo J, Yang L, Zhao Y, et al
   Ovarian Sclerosing Stromal Tumor and Mullerian Cyst in an 11-yr-old Girl: A Case Report and Review of the Literature.
   Int J Gynecol Pathol. 2020;39:e5-e10.
   PubMed     Abstract available
   
   
   
4. BAI S, Hutchinson LM, Meng X, Bai H, et al
   Dedifferentiated Carcinoma of the Endometrium Associated With Low-grade Mullerian Adenosarcoma: A Clinicopathologic Case Report Including the Immunohistochemical and Molecular Profile.
   Int J Gynecol Pathol. 2020;39:141-145.
   PubMed     Abstract available
   
   
   
5. VOS MC, Hollemans E, van der Steen SCHA, van Kuppevelt TH, et al
   Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma.
   Int J Gynecol Pathol. 2020;39:184-192.
   PubMed     Abstract available
   
   
   
6. COSTIGAN DC, Dong F, Nucci MR, Howitt BE, et al
   Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma.
   Int J Gynecol Pathol. 2020;39:119-127.
   PubMed     Abstract available
   
   
   
7. CHEN PH, Hui P, Buza N
   Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
   Int J Gynecol Pathol. 2020;39:193-198.
   PubMed     Abstract available
   
   
   
8. CHIESA-VOTTERO A
   CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
   Int J Gynecol Pathol. 2020;39:170-177.
   PubMed     Abstract available
   
   
   January 2020
9. MA Q, Yuan Y, Wang Y, Shao C, et al
   Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review.
   Int J Gynecol Pathol. 2020 Jan 23. doi: 10.1097/PGP.0000000000000663.
   PubMed     Abstract available
   
   
   
10. ANGELICO G, Santoro A, Arciuolo D, Valente M, et al
    Peritoneal Carcinomatosis From Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma.
    Int J Gynecol Pathol. 2020;39:e2-e3.
    PubMed    
    
    
    
11. IIZUKA N, Ikura Y, Fukuoka Y, Shibata T, et al
    Malignant Lymphoma of the Ovary: A Diagnostic Pitfall of Intraoperative Consultation.
    Int J Gynecol Pathol. 2020;39:79-83.
    PubMed     Abstract available
    
    
    
12. TURASHVILI G, Fix DJ, Soslow RA, Park KJ, et al
    Wilms Tumor of the Ovary: Review of the Literature and Report of 2 Cases.
    Int J Gynecol Pathol. 2020;39:72-78.
    PubMed     Abstract available
    
    
    
13. KUNO I, Tate K, Yoshida H, Takahashi K, et al
    Endometrial Endometrioid Carcinoma With Ovarian Metastasis Showing Morula-like Features in a Patient With Cowden Syndrome: A Case Report.
    Int J Gynecol Pathol. 2020;39:36-42.
    PubMed     Abstract available
    
    
    
14. MCCLUGGAGE WG, Vosmikova H, Laco J
    Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
    Int J Gynecol Pathol. 2020;39:84-92.
    PubMed     Abstract available
    
    
    
15. SEIDMAN JD, Savage J, Krishnan J, Vang R, et al
    Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary in 18 Patients With Peritoneal Carcinomatosis.
    Int J Gynecol Pathol. 2020;39:43-54.
    PubMed     Abstract available
    
    
    
16. PIERMATTEI A, Santoro A, Angelico G, Inzani F, et al
    Cerebellar Metastasis From Ovarian Carcinoma Harboring PIK3CA-Activating Mutation: A "Clear" Explanation for Unexpected "Vertigo".
    Int J Gynecol Pathol. 2020;39:68-71.
    PubMed     Abstract available
    
    
    
17. CHIESA-VOTTERO A
    Risk of Malignancy in Postmenopausal Patients With Ovarian Torsion.
    Int J Gynecol Pathol. 2020;39:e4.
    PubMed    
    
    
    November 2019
18. WOODBECK R, Kelemen LE, Kobel M
    Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
    Int J Gynecol Pathol. 2019;38:568-575.
    PubMed     Abstract available
    
    
    
19. LEBOK P, Zuna RE, Holman LL, Young RH, et al
    Multiple Luteinized Follicle Cysts of the Ovary in a Patient With a Pituitary Adenoma: Report of a Case and Review of the Literature.
    Int J Gynecol Pathol. 2019;38:562-567.
    PubMed     Abstract available
    
    
    
20. ROTH LM, Davis MM, Czernobilsky B
    Classic and "Dissecting" Gonadoblastoma in a Phenotypic Girl With a 46, XX Peripheral Karyotype and No Evidence of a Disorder of Sex Development.
    Int J Gynecol Pathol. 2019;38:581-587.
    PubMed     Abstract available
    
    
    
21. SAH S, McCluggage WG
    Ovarian Combined Brenner Tumor, Mucinous Cystadenoma and Struma Ovarii: First Report of a Rare Combination.
    Int J Gynecol Pathol. 2019;38:576-580.
    PubMed     Abstract available
    
    
    
22. MAGRILL J, Karnezis AN, Tessier-Cloutier B, Talhouk A, et al
    Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.
    Int J Gynecol Pathol. 2019;38:552-561.
    PubMed     Abstract available
    
    
    September 2019
23. KOH NWC, Seow WY, Lee YT, Lam JCM, et al
    Pericytoma With t(7;12): The First Ovarian Case Reported and a Review of the Literature.
    Int J Gynecol Pathol. 2019;38:479-484.
    PubMed     Abstract available
    
    
    
24. LI YP, Chang K, Chen TW, Lee SP, et al
    Primary Ewing Family of Tumor Arising in the Ovary: A Case Report.
    Int J Gynecol Pathol. 2019;38:470-473.
    PubMed     Abstract available
    
    
    
25. HUSSAIN I, Howard RS, Syed V, Allgauer M, et al
    A Cell Line-based Immunohistochemical p53 Expression Pattern Control Panel.
    Int J Gynecol Pathol. 2019;38:449-458.
    PubMed     Abstract available
    
    
    
26. CHOI YJ, Ho J, Yoo J, Liu J, et al
    Next-generation Sequencing of an Ovarian Spindle Cell Tumor Identified an Ovarian Low-grade Endometrial Stromal Sarcoma: A Rare Entity.
    Int J Gynecol Pathol. 2019;38:474-478.
    PubMed     Abstract available
    
    
    
27. XING D, Berrebi AA, Liu C, Richmond A, et al
    An Epithelioid Smooth Muscle Neoplasm Mimicking a Signet Ring Cell Carcinoma in the Ovary.
    Int J Gynecol Pathol. 2019;38:464-469.
    PubMed     Abstract available
    
    
    July 2019
28. KOBEL M, Luo L, Grevers X, Lee S, et al
    Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.
    Int J Gynecol Pathol. 2019;38:353-362.
    PubMed     Abstract available
    
    
    
29. UMEHARA R, Kurata A, Takanashi M, Hashimoto H, et al
    Fascin as a Useful Marker for Identifying Neural Components in Immature Teratomas of Human Ovary and Those Derived From Murine Embryonic Stem Cells.
    Int J Gynecol Pathol. 2019;38:377-385.
    PubMed     Abstract available
    
    
    
30. MA Q, Wu J
    Endometrioid Adenocarcinoma With Solitary Metastasis to the Appendix, Mimicking Primary Appendiceal Adenocarcinoma: A Case Report and Literature Review.
    Int J Gynecol Pathol. 2019;38:393-396.
    PubMed     Abstract available
    
    
    
31. TATE K, Yoshida H, Ishikawa M, Shimizu H, et al
    Endometrial Carcinoma With an Unusual Morphology in a Patient With Cornelia de Lange Syndrome: A Case Study.
    Int J Gynecol Pathol. 2019;38:340-345.
    PubMed     Abstract available
    
    
    
32. TAVALLAEE M, Steiner DF, Zehnder JL, Folkins AK, et al
    Coexistence of BRAF V600E and TERT Promoter Mutations in Low-grade Serous Carcinoma of Ovary Recurring as Carcinosarcoma in a Lymph Node: Report of a Case.
    Int J Gynecol Pathol. 2019;38:386-392.
    PubMed     Abstract available
    
    
    May 2019
33. PADHY RR, Savage J, Kurman RJ
    Comprehensive Surgical Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas: Is it Necessary?
    Int J Gynecol Pathol. 2019;38:241-246.
    PubMed     Abstract available
    
    
    
34. DITZEL HM, Strickland KC, Meserve EE, Stover E, et al
    Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).
    Int J Gynecol Pathol. 2019;38:230-240.
    PubMed     Abstract available
    
    
    
35. YAMAMOTO S, Sakai Y
    Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
    Int J Gynecol Pathol. 2019;38:247-252.
    PubMed     Abstract available
    
    
    March 2019
36. VISHWAJEET V, Banerjee N, Dey P
    Ovarian Lipoleiomyoma: A Rare Entity.
    Int J Gynecol Pathol. 2019;38:171-174.
    PubMed     Abstract available
    
    
    
37. STALL JN, Young RH
    Granulosa Cell Tumors of the Ovary With Prominent Thecoma-like Foci: A Report of 16 Cases Emphasizing the Ongoing Utility of the Reticulin Stain in the Modern Era.
    Int J Gynecol Pathol. 2019;38:143-150.
    PubMed     Abstract available
    
    
    
38. MILLS AM, Peres LC, Meiss A, Ring KL, et al
    Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).
    Int J Gynecol Pathol. 2019;38:157-170.
    PubMed     Abstract available
    
    
    
39. WONG RW, McCluggage WG
    Sex Cord-stromal Tumors With Steroid Cell Tumor and Fibroma Components: Report of 2 Cases, Including One of Extraovarian Origin.
    Int J Gynecol Pathol. 2019;38:151-156.
    PubMed     Abstract available
    
    
    January 2019
40. SOSLOW RA, Tornos C, Park KJ, Malpica A, et al
    Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
    Int J Gynecol Pathol. 2019;38 Suppl 1:S64-S74.
    PubMed     Abstract available
    
    
    
41. MURALI R, Davidson B, Fadare O, Carlson JA, et al
    High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Int J Gynecol Pathol. 2019;38 Suppl 1:S40-S63.
    PubMed     Abstract available
    
    
    
42. RABBAN JT, Gilks CB, Malpica A, Matias-Guiu X, et al
    Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
    Int J Gynecol Pathol. 2019;38 Suppl 1:S25-S39.
    PubMed     Abstract available
    
    
    
43. PARK JY, Park JY, Nam JH, Kim KR, et al
    Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium.
    Int J Gynecol Pathol. 2019;38:66-70.
    PubMed     Abstract available
    
    
    
44. GAN Q, Crumley S, Broaddus RR
    Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2019;38:44-51.
    PubMed     Abstract available
    
    
    
45. TAYLOR J, McCluggage WG
    Ovarian Sex Cord-stromal Tumors With Melanin Pigment: Report of a Previously Undescribed Phenomenon.
    Int J Gynecol Pathol. 2019;38:92-96.
    PubMed     Abstract available
    
    
    
46. SRDELIC S, Kuzmic-Prusac I, Spagnoli GC, Juretic A, et al
    MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer.
    Int J Gynecol Pathol. 2019;38:59-65.
    PubMed     Abstract available
    
    
    
47. RAJENDRAN S, Jensen D, McCluggage WG
    Ganglioneuroblastoma Arising in an Ovarian Dermoid Cyst: First Report in the Literature.
    Int J Gynecol Pathol. 2019;38:103-107.
    PubMed     Abstract available
    
    
    November 2018
48. LEE PJ, McNulty S, Duncavage EJ, Heusel JW, et al
    Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
    Int J Gynecol Pathol. 2018;37:581-589.
    PubMed     Abstract available
    
    
    
49. BENNETT JA, Young RH, Chuang AY, Lerwill MF, et al
    Ovarian Metastases of Breast Cancers With Signet Ring Cells: A Report of 17 Cases Including 14 Krukenberg Tumors.
    Int J Gynecol Pathol. 2018;37:507-515.
    PubMed     Abstract available
    
    
    
50. HAZAMA Y, Moriya T, Sugihara M, Sano R, et al
    The Analysis of Cell Cycle-related Proteins in Ovarian Clear Cell Carcinoma Versus High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2018;37:516-524.
    PubMed     Abstract available
    
    
    September 2018
51. MATRAI CE, Pirog EC, Ellenson LH
    Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
    Int J Gynecol Pathol. 2018;37:405-413.
    PubMed     Abstract available
    
    
    
52. CHAPEL DB, Joseph NM, Krausz T, Lastra RR, et al
    An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Mullerian Origin for Some Mesonephric Carcinomas.
    Int J Gynecol Pathol. 2018;37:448-459.
    PubMed     Abstract available
    
    
    
53. AMIT A, Sabo E, Zohar Y, Trugman E, et al
    Evaluation of Microscopic Changes in Fallopian Tubes of BRCA Mutation Carriers by Morphometric Analysis of Histologic Slides: A Preliminary Pilot Study.
    Int J Gynecol Pathol. 2018;37:460-467.
    PubMed     Abstract available
    
    
    
54. FANG H, Langstraat CL, Visscher DW, Folpe AL, et al
    Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
    Int J Gynecol Pathol. 2018;37:468-472.
    PubMed     Abstract available
    
    
    July 2018
55. BASSIOUNY D, El-Baz MA, Gamil TM, Shams N, et al
    Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
    Int J Gynecol Pathol. 2018 Jul 27. doi: 10.1097/PGP.0000000000000533.
    PubMed     Abstract available
    
    
    
56. STEWART CJR, Crook ML
    Cerebellar Differentiation in Ovarian Teratoma: A Report of 6 Cases.
    Int J Gynecol Pathol. 2018;37:316-323.
    PubMed     Abstract available
    
    
    
57. JU B, Wang J, Yang B, Sun L, et al
    Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2018;37:388-396.
    PubMed     Abstract available
    
    
    
58. SINGH N, Benson JL, Gan C, Anglesio M, et al
    Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
    Int J Gynecol Pathol. 2018;37:324-330.
    PubMed     Abstract available
    
    
    
59. HOLMES M, Robb T
    A Rare Case of Primary Apocrine Adenocarcinoma Arising Within a Mature Cystic Teratoma of the Ovary, Metastatic to a Supraclavicular Lymph Node.
    Int J Gynecol Pathol. 2018;37:344-346.
    PubMed     Abstract available
    
    
    
60. BUZA N, Wong S, Hui P
    FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Int J Gynecol Pathol. 2018;37:305-315.
    PubMed     Abstract available
    
    
    
61. HONG S, Cui J, Li L, Buscema J, et al
    Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.
    Int J Gynecol Pathol. 2018;37:331-337.
    PubMed     Abstract available
    
    
    
62. SIMONS M, Ebisch I, de Hullu J, van Ham M, et al
    A Patient With a Low-grade Mucinous Neoplasm Involving the Ovary and Pseudomyxoma Peritonei Originating in an Isolated Intestinal Duplication.
    Int J Gynecol Pathol. 2018;37:338-343.
    PubMed     Abstract available
    
    
    May 2018
63. ONDIC O, Sidlova H, Alaghehbandan R
    Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Int J Gynecol Pathol. 2018 May 10. doi: 10.1097/PGP.0000000000000517.
    PubMed    
    
    
    
64. COY S, Meserve E, Berkowitz R, Hirsch MS, et al
    De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary.
    Int J Gynecol Pathol. 2018;37:296-300.
    PubMed     Abstract available
    
    
    
65. WOLSKY RJ, Price MA, Zaloudek CJ, Rabban JT, et al
    Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Int J Gynecol Pathol. 2018;37:262-274.
    PubMed     Abstract available
    
    
    
66. TAS EE, Yegin Akcay GF, Yildirim F, Yavuz F, et al
    Coexisting Primary Ovarian and Omental Hydatid Disease Mimicking an Ovarian Neoplasm: A Case Report.
    Int J Gynecol Pathol. 2018;37:301-304.
    PubMed     Abstract available
    
    
    
67. RONAGHY A, Xiao GQ, Santagada E, Hasanovic A, et al
    Expression of GATA-3 in Testicular and Gynecologic Mesothelial Neoplastic and Non-neoplastic Tissues.
    Int J Gynecol Pathol. 2018;37:284-289.
    PubMed     Abstract available
    
    
    
68. AL-HUSSAINI M, Al-Othman Y, Hijazi E, McCluggage WG, et al
    A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
    Int J Gynecol Pathol. 2018;37:275-283.
    PubMed     Abstract available
    
    
    
69. VAN ROMPUY AS, Vanderstichele A, Vergote I, Moerman P, et al
    Diffusely Metastasized Adenocarcinoma Arising in a Mucinous Carcinoid of the Ovary: A Case Report.
    Int J Gynecol Pathol. 2018;37:290-295.
    PubMed     Abstract available
    
    
    March 2018
70. NIU D, Li Z, Sun L, Cao D, et al
    Carcinoid Arising From the Teratomatous Bronchial Mucosa in a Mature Cystic Teratoma of the Ovary: A Case Report.
    Int J Gynecol Pathol. 2018;37:123-127.
    PubMed     Abstract available
    
    
    
71. RAWISH KR, Buza N, Zheng W, Fadare O, et al
    Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.
    Int J Gynecol Pathol. 2018;37:174-190.
    PubMed     Abstract available
    
    
    
72. ZADEH SL, Duska LR, Mills AM
    Androgen Receptor Expression in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2018;37:167-173.
    PubMed     Abstract available
    
    
    
73. SINGH K, Patel N, Patil P, Paquette C, et al
    Primary Ovarian Solid Pseudopapillary Neoplasm With CTNNB1 c.98C>G (p.S33C) Point Mutation.
    Int J Gynecol Pathol. 2018;37:110-116.
    PubMed     Abstract available
    
    
    January 2018
74. XING D, Jenson EG, Zwick CA, Rodriguez FJ, et al
    Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
    Int J Gynecol Pathol. 2018;37:52-56.
    PubMed     Abstract available
    
    
    
75. LONGWORTH A, Ganesan R, Yoong AKH, Hirschowitz L, et al
    Microscopic Heterotopic Extraovarian Sex Cord-Stromal Proliferations: Expanding the Histologic Spectrum.
    Int J Gynecol Pathol. 2018;37:35-43.
    PubMed     Abstract available
    
    
    
76. SANCI M, Gungorduk K, Gulseren V, Karadeniz T, et al
    MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
    Int J Gynecol Pathol. 2018;37:17-21.
    PubMed     Abstract available
    
    
    
77. GOLDBERG A, Hand L, DeCotiis D, Rosenblum N, et al
    Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
    Int J Gynecol Pathol. 2018;37:44-51.
    PubMed     Abstract available
    
    
    May 2017
78. MARTIN DE LA FUENTE L, Malander S, Hartman L, Jonsson JM, et al
    Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Int J Gynecol Pathol. 2017 May 5. doi: 10.1097/PGP.0000000000000394.
    PubMed     Abstract available
    
    
    March 2017
79. SAID I, Bohm S, Beasley J, Ellery P, et al
    The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:172-179.
    PubMed     Abstract available
    
    
    
80. NEWTON CL, Brockbank E, Singh N, Faruqi A, et al
    A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature.
    Int J Gynecol Pathol. 2017;36:195-199.
    PubMed     Abstract available
    
    
    
81. HJORTKJAER M, Waldstrom M, Jakobsen A, Kanstrup H, et al
    The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
    Int J Gynecol Pathol. 2017;36:180-189.
    PubMed     Abstract available
    
    
    
82. CHOUGULE A, Dey P
    Hilus Cell Heterotopia With Intraneural Eutopia.
    Int J Gynecol Pathol. 2017;36:200-202.
    PubMed    
    
    
    
83. SANGOI AR, Kshirsagar M, Horvai AE, Roma AA, et al
    SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Int J Gynecol Pathol. 2017;36:140-145.
    PubMed     Abstract available
    
    
    
84. CHEN W, Husain A, Nelson GS, Rambau PF, et al
    Immunohistochemical Profiling of Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:128-139.
    PubMed     Abstract available
    
    
    November 2016
85. GRAY S, Chen Y, Litton T, Jallad B, et al
    Synchronous Ileal Neuroendocrine Tumor and Ovarian Steroid Cell Tumor Present in a Female With Hyperandrogenism.
    Int J Gynecol Pathol. 2016;35:554-560.
    PubMed     Abstract available
    
    
    
86. GOEBEL EA, McCluggage WG, Walsh JC
    Mitotically Active Sclerosing Stromal Tumor of the Ovary: Report of a Case Series With Parallels to Mitotically Active Cellular Fibroma.
    Int J Gynecol Pathol. 2016;35:549-553.
    PubMed     Abstract available
    
    
    
87. LIU C, Gallagher RL, Price GR, Bolton E, et al
    Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.
    Int J Gynecol Pathol. 2016;35:561-565.
    PubMed     Abstract available
    
    
    
88. MUTUIRI AP, Nzioka A, Busarla SV, Sayed S, et al
    Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma.
    Int J Gynecol Pathol. 2016;35:537-543.
    PubMed     Abstract available
    
    
    March 2016
89. STOLNICU S, Molnar C, Barsan I, Boros M, et al
    The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.
    Int J Gynecol Pathol. 2016;35:147-52.
    PubMed     Abstract available
    
    
    
90. ARAUJO IB, Pinheiro MV, Zanvettor PH, Studart EJ, et al
    High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Int J Gynecol Pathol. 2016;35:176-84.
    PubMed     Abstract available
    
    
    
91. GOYAL A, Masand RP, Roma AA
    Value of PAX-8 and SF-1 Immunohistochemistry in the Distinction Between Female Adnexal Tumor of Probable Wolffian Origin and its Mimics.
    Int J Gynecol Pathol. 2016;35:167-75.
    PubMed     Abstract available
    
    
    
92. STANHISER J, Mahdi H, Rosa G, Harper H, et al
    Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma.
    Int J Gynecol Pathol. 2016;35:185-90.
    PubMed     Abstract available
    
    
    January 2016
93. KURMAN RJ, Shih IeM
    Seromucinous Tumors of the Ovary. What's in a Name?
    Int J Gynecol Pathol. 2016;35:78-81.
    PubMed     Abstract available
    
    
    
94. WHEELER L, Westhoff GL, O'Keefe MC, Kong CS, et al
    Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2016;35:72-7.
    PubMed     Abstract available
    
    
    
95. OHISHI Y, Imamura H, Aman M, Shida K, et al
    Is Invasive Micropapillary Serous Carcinoma a Low-grade Carcinoma?
    Int J Gynecol Pathol. 2016;35:56-65.
    PubMed     Abstract available
    
    
    
96. KATO N, Uchigasaki S, Fukase M, Kurose A, et al
    Expression of P450 Aromatase in Granulosa Cell Tumors and Sertoli-Stromal Cell Tumors of the Ovary: Which Cells Are Responsible for Estrogenesis?
    Int J Gynecol Pathol. 2016;35:41-7.
    PubMed     Abstract available
    
    
    
97. SUDOUR-BONNANGE H, Rocourt N, Aubry E, Lervat C, et al
    A Sex Cord-stromal Tumor, Specifically a Fibroma, Arising From the Uterine Corpus: A Case Report.
    Int J Gynecol Pathol. 2016;35:33-7.
    PubMed     Abstract available
    
    
    
98. HUSSEIN YR, Broaddus R, Weigelt B, Levine DA, et al
    The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Int J Gynecol Pathol. 2016;35:16-24.
    PubMed     Abstract available
    
    
    
99. HUANG W, Cheng X, Ji J, Zhang J, et al
    The Application Value of HNF-1beta Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2016;35:66-71.
    PubMed     Abstract available
    
    
    
100. VANG R, Levine DA, Soslow RA, Zaloudek C, et al
     Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
     Int J Gynecol Pathol. 2016;35:48-55.
     PubMed     Abstract available
     
     
     
101. OKOYE EI, Bruegl AS, Fellman B, Luthra R, et al
     Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.
     Int J Gynecol Pathol. 2016;35:8-15.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: